141 related articles for article (PubMed ID: 26174437)
1. A study of the relationship of metabolic MR parameters to estrogen dependence in breast cancer xenografts.
Liu T; Nath K; Liu W; Zhou R; Chen IW
NMR Biomed; 2015 Sep; 28(9):1087-96. PubMed ID: 26174437
[TBL] [Abstract][Full Text] [Related]
2. Effect of estrogen withdrawal on energy-rich phosphates and prediction of estrogen dependence monitored by in vivo 31P magnetic resonance spectroscopy of four human breast cancer xenografts.
Kristensen CA; Kristjansen PE; Brünner N; Clarke R; Spang-Thomsen M; Quistorff B
Cancer Res; 1995 Apr; 55(8):1664-9. PubMed ID: 7712472
[TBL] [Abstract][Full Text] [Related]
3. Correlations between 31P-NMR spectroscopy and tissue O2 tension measurements in a murine fibrosarcoma.
Vaupel P; Okunieff P; Kallinowski F; Neuringer LJ
Radiat Res; 1989 Dec; 120(3):477-93. PubMed ID: 2594969
[TBL] [Abstract][Full Text] [Related]
4. Growth inhibition in response to estrogen withdrawal and tamoxifen therapy of human breast cancer xenografts evaluated by in vivo 31P magnetic resonance spectroscopy, creatine kinase activity, and apoptotic index.
Kristensen CA; Kristjansen PE; Brünner N; Quistorff B; Spang-Thomsen M
Cancer Res; 1995 Sep; 55(18):4146-50. PubMed ID: 7664292
[TBL] [Abstract][Full Text] [Related]
5. Metabolic studies of estrogen- and tamoxifen-treated human breast cancer cells by nuclear magnetic resonance spectroscopy.
Neeman M; Degani H
Cancer Res; 1989 Feb; 49(3):589-94. PubMed ID: 2562927
[TBL] [Abstract][Full Text] [Related]
6. Effects of a pure antiestrogen on apoptosis and proliferation within human breast ductal carcinoma in situ.
Gandhi A; Holland PA; Knox WF; Potten CS; Bundred NJ
Cancer Res; 2000 Aug; 60(15):4284-8. PubMed ID: 10945643
[TBL] [Abstract][Full Text] [Related]
7. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
Morrissey JJ; Raney S
Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
[TBL] [Abstract][Full Text] [Related]
8. Multiparametric MRI With Dynamic Contrast Enhancement, Diffusion-Weighted Imaging, and 31-Phosphorus Spectroscopy at 7 T for Characterization of Breast Cancer.
Schmitz AM; Veldhuis WB; Menke-Pluijmers MB; van der Kemp WJ; van der Velden TA; Kock MC; Westenend PJ; Klomp DW; Gilhuijs KG
Invest Radiol; 2015 Nov; 50(11):766-71. PubMed ID: 26135017
[TBL] [Abstract][Full Text] [Related]
9. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice.
Osborne CK; Hobbs K; Clark GM
Cancer Res; 1985 Feb; 45(2):584-90. PubMed ID: 3967234
[TBL] [Abstract][Full Text] [Related]
10. [Changes in 31P-MR spectroscopy in murine experimental tumor (SCC VII) after irradiation].
Hori H; Itoh Y; Aihara M; Ayakawa Y; Miyata N
Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Jul; 53(7):847-55. PubMed ID: 8378146
[TBL] [Abstract][Full Text] [Related]
11. Intracellular pH measurements of the whole head and the basal ganglia in chronic liver disease: a phosphorus-31 MR spectroscopy study.
Patel N; Forton DM; Coutts GA; Thomas HC; Taylor-Robinson SD
Metab Brain Dis; 2000 Sep; 15(3):223-40. PubMed ID: 11206591
[TBL] [Abstract][Full Text] [Related]
12. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro.
Reddel RR; Sutherland RL
Cancer Res; 1987 Oct; 47(20):5323-9. PubMed ID: 3652038
[TBL] [Abstract][Full Text] [Related]
13. Phosphorus-31 metabolism of post-menopausal breast cancer studied in vivo by magnetic resonance spectroscopy.
Twelves CJ; Porter DA; Lowry M; Dobbs NA; Graves PE; Smith MA; Rubens RD; Richards MA
Br J Cancer; 1994 Jun; 69(6):1151-6. PubMed ID: 8198985
[TBL] [Abstract][Full Text] [Related]
14. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors.
Read LD; Greene GL; Katzenellenbogen BS
Mol Endocrinol; 1989 Feb; 3(2):295-304. PubMed ID: 2785242
[TBL] [Abstract][Full Text] [Related]
15. Effects of CH4893237, a new orally active estrogen receptor downregulator, on breast cancer xenograft models with low serum estrogen levels.
Yoneya T; Tsunenari T; Taniguchi K; Kanbe Y; Morikawa K; Yamada-Okabe H; Lee YH; Lee MH; Kwon LS
Oncol Rep; 2009 Mar; 21(3):747-55. PubMed ID: 19212635
[TBL] [Abstract][Full Text] [Related]
16. Effects of pentobarbital anesthesia on the energy metabolism of murine tumors studied by in vivo 31P nuclear magnetic resonance spectroscopy.
Okunieff P; Rummeny E; Vaupel P; Skates S; Willett C; Neuringer LJ; Suit HD
Radiat Res; 1988 Aug; 115(2):361-72. PubMed ID: 3406373
[TBL] [Abstract][Full Text] [Related]
17. Cerebral metabolism in experimental hydrocephalus: an in vivo 1H and 31P magnetic resonance spectroscopy study.
Braun KP; van Eijsden P; Vandertop WP; de Graaf RA; Gooskens RH; Tulleken KA; Nicolay K
J Neurosurg; 1999 Oct; 91(4):660-8. PubMed ID: 10507389
[TBL] [Abstract][Full Text] [Related]
18. Reversal of tamoxifen resistant breast cancer by low dose estrogen therapy.
Osipo C; Gajdos C; Cheng D; Jordan VC
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):249-56. PubMed ID: 15860267
[TBL] [Abstract][Full Text] [Related]
19. Response of choline metabolites to docetaxel therapy is quantified in vivo by localized (31)P MRS of human breast cancer xenografts and in vitro by high-resolution (31)P NMR spectroscopy of cell extracts.
Morse DL; Raghunand N; Sadarangani P; Murthi S; Job C; Day S; Howison C; Gillies RJ
Magn Reson Med; 2007 Aug; 58(2):270-80. PubMed ID: 17654590
[TBL] [Abstract][Full Text] [Related]
20. Oral fluoropyrimidine may augment the efficacy of aromatase inhibitor via the down-regulation of estrogen receptor in estrogen-responsive breast cancer xenografts.
Nukatsuka M; Saito H; Nakagawa F; Abe M; Uchida J; Shibata J; Matsuo K; Noguchi S; Kiniwa M
Breast Cancer Res Treat; 2011 Jul; 128(2):381-90. PubMed ID: 20809360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
